跳至主要内容
临床试验/ISRCTN13889391
ISRCTN13889391已完成未知

A clinical study investigating the benefits of a hydroxyapatite/potassium nitrite and aluminium lactate cosmetic toothpaste to help the discomfort associated with dentine hypersensitivity compared to a benchmark marketed toothpaste

niversity of Bristol0 个研究点目标入组 82 人开始时间: 2020年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
82

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33647373/ results (added 17/03/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Voluntary written informed consent given
  • 2. Aged 18 to 65 years
  • 3. Good general and mental health in the opinion of the investigator or medically qualified designee
  • a. No clinically significant and relevant abnormalities of medical history or oral examination
  • b. No condition that would impact on safety, wellbeing or ability to understand and follow study procedures and requirements
  • 4. Understands and is willing, able and likely to comply with all study procedures and restrictions
  • 5. Minimum of 20 natural teeth
  • 6. 2 sensitive teeth as defined by Schiff scores 2/3 to evaporative stimuli
  • 7. Minimum of two, non-adjacent accessible teeth (incisors, canines, pre-molars), that have signs of sensitivity, measured by qualifying tactile stimulus (Yeaple = 20g) and evaporative air assessment (Schiff sensitivity score = 2)

排除标准

  • 1. Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
  • 2. Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 15 days of the screening visit
  • 3. Previous participation in this study
  • 4. Recent history (within the last year) of alcohol or other substance abuse
  • 5. An employee of the sponsor or members of their immediate family
  • 6. An employee of the site for this protocol (the Bristol Dental School and Hospital) and associated with the Clinical Trials unit
  • 6. Presence of chronic debilitating disease which, in the opinion of the investigator, could affect study outcomes.
  • 7. Any condition which, in the opinion of the investigator, causes xerostomia
  • 8. Dental prophylaxis within 4 weeks of screening
  • 9. Tongue or lip piercing
  • 10. Desensitizing treatment within 2 weeks of screening (professional sensitivity treatments and non-dentifrice sensitivity treatments)
  • 11. Active periodontal disease
  • 12. Teeth bleaching within 8 weeks of screening
  • 13. Teeth with exposed dentine but used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel
  • 14. Teeth with evidence of caries
  • 15. Daily prescription of medication/treatments which, in the opinion of the investigator, could interfere with the perception of pain. Including but not limited to: analgesics, anticonvulsants, antihistamines that cause marked or moderate sedation, sedatives, tranquilizers, anti-depressants, and mood-altering and anti-inflammatory drugs.
  • 16. Any subject who, in the judgment of the investigator, should not participate in the study

研究者

发起方
niversity of Bristol

相似试验